Adult-onset deficiency of adenosine deaminase 2—a case report and literature review
- 26 February 2021
- journal article
- review article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (10) , 4325-4339
Abstract
Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease caused by ADA2 gene mutation that is characterized by three phenotype domains: vasculopathy and inflammation, hematological abnormality, and immunodeficiency. Most patients are pediatric patients; adult-onset patients are only occasionally reported. To describe a Chinese case of adult-onset DADA2 in a Chinese patient and explore the genotype and phenotype characteristics of adult-onset DADA2. We examined the clinical, serological, and genetic features of a Chinese adult-onset DADA2 patient. English literature on DADA2 was reviewed. The clinical and genetic characteristics of different age and mutation subgroups were compared. A Chinese Han male presented with recurrent fever, rash, immunodeficiency, and significant vascular events since the age of 25 years. Serum ADA2 activity was diminished, and genotyping revealed a unique compound heterozygous mutation of exon2-10del/exon7del in the ADA2 gene leading to complete exon 7 deletion. Treatment with a TNFα inhibitor achieved disease control. A total of 269 cases carrying 102 mutations were analyzed through a literature review. Adult-onset patients had few symptoms in all three clinical domains; vasculopathy and inflammation were the major symptoms. Patients with null mutations had early disease onset and more frequent hematological abnormalities and immunodeficiency. Patients in all subgroups responded well to TNFα inhibitors. We reported the first Chinese adult-onset DADA2 patient, with a unique mutation. Screening for and differentiation of DADA2 are recommended for patients of all ages, as they might become symptomatic later in life and treatment strategies differ from those of traditional vasculitis. Key Points • We report a novel compound heterozygous deletion mutations of exons 2–10 and exon 7, leading to complete loss of exon 7 in the ADA2 gene. • Adult-onset DADA2 patients had high similarity to systemic vasculitis. • Null mutations contribute to earlier disease onset and more aggressive disease. • We suggest screening for DADA2 in patients with significant central vasculitis, hematological abnormality and immunodeficiency.Keywords
Funding Information
- Natural Science Foundation of Beijing (No.7192170)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (No. 2017-I2M-3-001)
- the national key Research and Development Program of China (No.2016YFC0901500, 2016YFC0901501)
- the Chinese Academy of Medical Sciences innovation fund for medical sciences (No. 2016-I2M-1-002)
- The National Natural Science Foundation of China (No. 81788101)
- Capital Medical Development Research Fund (No.2018-1-4012)
- Clinical and translational medical research fund of Chinese Academy of Medical Sciences (No. 2019XK320013)
- Fundamental Research Funds for the Central Universities (No. APL20100310010301019)
- CAMS Initiative for Innovative Medicine (No.2016-I2M-1-008)
- The capital health research and development of special (No.2016-2-40114)
This publication has 38 references indexed in Scilit:
- Extending the Clinical Phenotype of Adenosine Deaminase 2 DeficiencyThe Journal of Pediatrics, 2016
- Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantationJournal of Allergy and Clinical Immunology, 2016
- ADA2 deficiency: case report of a new phenotype and novel mutation in two sistersRMD Open, 2016
- Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen CasesArthritis & Rheumatology, 2016
- IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammationJournal of Allergy and Clinical Immunology, 2016
- Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutationsRheumatology, 2016
- Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa VasculopathyNew England Journal of Medicine, 2014
- Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2New England Journal of Medicine, 2014
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Structural Basis for the Growth Factor Activity of Human Adenosine Deaminase ADA2Journal of Biological Chemistry, 2010